Inner nuclear membrane (INM) protein composition regulates nuclear function, affecting processes such as gene expression, chromosome organization, nuclear shape and stability.
Introduction
The nucleus is the defining feature of eukaryotic cells. Successful propagation of nuclei, and the genome contained within their walls, is vital for an organism's survival. Although the double lipid bilayer that forms the nuclear envelope (NE) is often viewed as a fortress, the inner and outer nuclear membranes (INM and ONM) are highly dynamic structures that undergo changes in structure and composition throughout development and differentiation, in mitosis and meiosis, and in diseased and dying cells (CHEN et al. 2014; DAUER AND WORMAN 2009; GORDON et al. 2014) . Lobulated nuclei with aberrant membranes and abnormal chromosome configurations are used to grade many tumors; however, similar changes in nuclear shape and genome organization also occur during the maturation of normal cell types, most notably during hematopoiesis, suggesting a complexity at the NE that we are just beginning to understand (SKINNER AND JOHNSON 2017) . As many of the unique properties of the NE, such as its (ANTONIN et al. 2011; FURUKAWA et al. 1998; ; UNGRICHT WU et al. 2002) . A small subset of proteins is targeted to the INM by a specific sequence motif, which is recognized by the nuclear translocation machinery (GARDNER et al. 2011; KING et al. 2006; LUSK et al. 2007; TAPLEY et al. 2011; TURGAY et al. 2010) . Additional mechanisms of INM transport have also been proposed that bypass the NPC and rely on the budding and fusion of vesicles from ONM to INM (METTENLEITER 2016; SPEESE et al. 2012) . While many mechanistic details regarding INM transport are still poorly understood, it seems clear that the INM has a distinct composition from the ONM, which is contiguous with the endoplasmic reticulum (ER).
In the ER, misfolded or damaged proteins are targeted for degradation by the ERassociated degradation pathway (ERAD) as part of the cell's surveillance system to prevent the formation of non-functional complexes or aggregates of defective protein (ZATTAS AND HOCHSTRASSER 2015) . The conserved E3 ligases Doa10/MARCH6/TEB4 and Hrd1/SYVN1 recognize lesions in the cytosolic or luminal/membrane regions of ER proteins, respectively, resulting in ubiquitination and retro-translocation of defective proteins back into the cytoplasm for destruction by the 26S proteasome (ZATTAS AND HOCHSTRASSER 2015) . Although ERAD likely ensures that ONM proteins are functional and present in the correct stoichiometry, it is unclear if this pathway operates at the INM due to its separation from the ONM/ER by NPCs (BOBAN . Instead, an INM-associated degradation (INMAD) has been proposed to remove mistargeted proteins from the INM through ubiquitin-mediated proteolysis (FORESTI et al. 2014; KHMELINSKII et al. 2014) . Three putative E3 ligases have been implicated in INMAD in yeast (Doa10, Asi1 and Asi3) and a handful of substrates have been identified based on increased whole cell protein levels in cells lacking the ligases. Interestingly, these INMAD substrates are not INM components but are proteins mistargeted to the INM, such as a mutant version of the Sec61 translocon, vacuolar transport complex subunits and multiple plasma membrane transporters (FORESTI et al. 2014; KHMELINSKII et al. 2014) . The mechanisms by which INMAD distinguishes between 'foreign' and 'resident' membrane proteins, and whether INMAD targets damaged or misfolded INM components through a pathway similar to ERAD remains unknown. Examination of protein stability in rats using isotope labeling suggested that NPCs and INM proteins such as lamins are extremely long-lived, leading to the general idea that the INM is stable, with little protein turnover (SAVAS et al. 2012) . One important exception 5 occurs under nutrient deprivation when non-essential sections of the entire nucleus, including the INM, are pinched off into the vacuole (the yeast lysosome) and degraded, a process known as piecemeal nuclear autophagy (PMNA) (ADNYANA et al. 2000; DO et al. 2003; MILLEN et al. 2009; ROBERTS et al. 2003) . PMNA has not yet been identified in higher eukaryotes, but autophagy of NE proteins in mammalian cells occurs (DOU et al. 2015; PARK et al. 2009 ) and is linked to both cancer and aging (MARTINEZ-LOPEZ et al. 2015; WHITE et al. 2015) . However, a role for INMAD outside of yeast has not been reported.
We previously described a method using split-GFP that allowed us to systematically and unequivocally assay the ability of budding yeast membrane proteins to access the INM (SMOYER et al. 2016) . Unlike biochemical methods for studying INM composition that depend on in silico subtraction or comparative analysis of nuclear and microsomal membrane samples (an ER derived fraction formed in vitro), our assay is specific for the INM pool of protein, allowing for analysis of proteins that have dual functions. The assay also discriminates the INM from ONM using endogenously expressed proteins that serve as the sole copy in the cell and can be used in live cells. To test the contribution of INMAD on INM composition, we compared the distribution of proteins using split-GFP in wild-type cells to that of cells lacking ASI1.
Comparison of INM composition in cells lacking other protein quality control components such as the INMAD/ERAD E3 ligase Doa10, the ERAD E3 ligase Hrd1, the E2 ubiquitin conjugating enzyme Ubc7 and the vacuolar peptidase Pep4, revealed 74 proteins whose INM levels increased specifically in cells lacking ASI1, suggesting direct or indirect regulation by Asi1. In asi1∆, we also observed an increase in the size and frequency of INM puncta containing Pom33/Tts1/TMEM33, a conserved NPC-localized protein that plays a role in NPC distribution, biogenesis and/or stability (CHADRIN et al. 2010; URADE et al. 2014; ZHANG AND OLIFERENKO 2014) . We provide evidence that Pom33 is directly ubiquitinated by Asi1; however, ubiquitination of Pom33 does not lead to turnover, but instead contributes to proper Pom33 INM distribution.
Results

Screen for INM changes in protein quality control mutants
To detect if proteins are able to access the INM, we express a soluble nuclear protein at high levels fused to half of split-GFP (GFP11-mCherry-Pus1); this can reconstitute a working GFP when a protein fused to GFP1-10 localizes to the same compartment ( Figure 1A ). Previously, we showed that 312 of 1010 C-terminally tagged membrane or predicted membrane proteins in yeast have access to the INM using the split-GFP assay (SMOYER et al. 2016) . To determine how the INM proteome is altered by removal of quality control systems, we examined INM localization of the same library in cells lacking ASI1 (INMAD), DOA10 (INMAD/ERAD), HRD1 (ERAD), UBC7 (INMAD/ERAD and other pathways) and PEP4 (vacuole). Wild-type and mutant strains were screened using a high-throughput 96-well plate imaging format, and images were quantitatively assessed for INM signal using an automated image analysis pipeline. Although it is unlikely that the amount of nuclear reporter is limiting as it is present in high copy, levels of GFP11-mCherry-Pus1 could affect the amount of 488 fluorescence visualized, so we first normalized to mCherry levels on a cell by cell basis. Next, we averaged split-GFP signal for each protein/mutant combination to eliminate possible cell cycle/cell growth artifacts and then used this value to determine the final intensity ratio of wild-type and each mutant (Table S1 ).
Manual inspection of images in cells lacking ASI1 compared to wild-type showed that only 725 of the 833 genes tested in the mutant could be reliably scored. Most (84/105) of the 105 false positives (Table S2 ) correspond to proteins absent from the INM of both wild-type and asi1∆; for the remainder (21/105), we suspect that low expression levels and higher levels of autofluorescence resulted in ambiguous scoring, so these were eliminated from our library and were not included in analysis of any mutants. The mating pheromone receptor Ste2 was also a false positive due to the MATa mating type of strains used for mutant analysis versus the MATα 7 strain we used for wild-type ( Figure S1 ). If we examined Ste2-GFP1-10 in a wild-type MATa strain, it localizes to the INM like the mutants ( Figure S1 ). No other INM components were obviously affected by mating type.
Our analysis showed that the distribution of most proteins was unaffected in the deletions, resulting in ratio values around 1 (Figure 1B-C) . Using a cut-off of 1.4, which is slightly less than one standard deviation above the mean for most samples, we found that 10-26% of proteins showed an increase above wild-type. This included increased levels for 74/725 proteins in asi1∆, 177/672 in ubc7∆, 97/705 in doa10∆, 105/707 in hrd1∆ and 141/686 in pep4∆ ( Figure   1E ). These hits could be further subdivided into three categories based on their localization in wild-type. For example, 21 proteins present at the INM in asi1∆ did not localize to the INM in wild-type, 10 were soluble and nucleoplasmic and 43 were at the INM but increased in cells lacking ASI1 (Figure 1D-E) . This over-representation of INM components in asi1∆ (58%) compared to other mutants (34%) strongly suggests that Asi1 affects native INM components.
Consistent with this idea, the well-characterized INM components Pom33, Per33, Asi2 and Heh2 were identified as hits in our asi1∆ screen but not in other mutants (Table S1 and S3), as discussed below.
In each mutant analyzed, we identified increased INM access of a unique combination of splitGFPs (Table S3 ). Cells lacking the E2 ubiquitin-conjugating enzyme Ubc7 partially overlapped with the E3 ligases, consistent with the idea that Ubc7 plays a role in both ERAD and INMAD.
The partial overlap between doa10∆ and hrd1∆ or asi1∆ mutants ( Figure S2A ) is similar to previous reports suggesting that Doa10 also plays a role in both pathways (FORESTI et al. 2014; KHMELINSKII et al. 2014) . The limited overlap between our split-GFP library and the tandem timer library used by Khmelinskii et al only allowed us to test 12 of 20 previously reported Asi1 substrates (KHMELINSKII et al. 2014) . From this, we confirmed increased INM localization in eight of the twelve, including the vacuolar transferase complex subunit Vtc1 that is thought to be mistargeted to the INM due to protein tagging (KHMELINSKII et al. 2014) , the Rab GTPase interacting protein Yip4, the plasma membrane transporter Zrt2, inositolphosphotransferase Ipt1, and Irc23, a protein of unknown function that is linked to DNA damage ( Figure S2B ). We also saw similar effects for ubc7∆, but interestingly, our screen showed little or no overlap in doa10∆ and hrd1∆ substrates ( Figure S2B ) (FORESTI et al. 2014; KHMELINSKII et al. 2014) . It is unknown if protein levels and/or INM localization is a direct or indirect consequence of the Asi1 deletion; therefore, we performed more detailed analysis on a subset of mutants and proteins.
Pom33 distribution is altered in cells lacking ASI1
In addition to a change in protein levels, one of the most interesting phenotypes that we observed in INM quality control mutants was the appearance of puncta-increased levels of INM protein at one or more NE locations in the presence of background fluorescence throughout the membrane. A striking example is shown in Figure 2A puncta formation is specific to Pom33 and Per33 and not a general feature of INM or NPC pore components in asi1∆. Pom34 was identified as a potential Ubc7-dependent, Hrd1-and Doa10-independent target in a previous proteomic screen for Asi1 targets (FORESTI et al. 2014 ) and in our analysis, it did exhibit a slight ratio increase for asi1∆ (1.27) and ubc7∆ (1.35). Unlike the puncta formation we previously observed for a number of proteins using split-GFP (SMOYER et al. 2016) , the puncta formed by Pom33 were specifically linked to INM quality control pathways, forming in mutant cells lacking ASI1, ASI2, UBC7 and to a lesser extent ASI3 (Figure 2A , 2C & S3). Per33 puncta also formed in ERAD mutants ( Figure S3 ) and were not studied further.
Quantitation of Pom33 at the INM showed that there was little change in intensity or total Pom33 levels in wild-type and mutants ( Figure 2A & B) , but the frequency of puncta more than doubled in asi1∆ and asi2∆ cells ( Figure 2C ). These structures were also considerably larger than in wild-type cells ( Figure 2D ), suggesting that Asi1 and Asi2 affect Pom33 distribution at the INM.
Ubiquitination of Pom33 regulates INM distribution but not degradation
To understand how Asi1 and Asi2 affect Pom33 distribution at the INM, we considered the possibility that Pom33 is a target of the ubiquitin ligase activity of Asi1 and is ubiquitinated in vivo. Ubiquitinated proteins were immunoprecipitated from lysates containing Pom33 and Pom33-GFP1-10, with and without ASI1 with an anti-ubiquitin antibody. As a positive control, we immunoprecipitated an N-terminal fusion of ubiquitin to Pom33-GFP1-10 (Ub-Pom33). We analyzed these immunoprecipitates by western blotting with an anti-GFP antibody. Although a ladder of bands was not present to indicate poly-ubiquitination, we enriched for Pom33-GFP1-10 from wild-type but not asi1∆ cells in these experiments ( Figure 3A -B), suggesting that Pom33 is ubiquitinated in an Asi1-dependent manner.
Total Pom33 proteins levels do not change in asi1∆ ( Figure 2B ) and it does not appear to be poly-ubiquitinated ( Figure 3A ), suggesting Pom33 is not actively degraded. To formally test whether Pom33 is degraded by the 26S proteasome, we examined the stability of Pom33-13xmyc in wild-type cells compared to cim3-1, a mutant that disrupts the proteasome lid component Rpt6 (GHISLAIN et al. 1993; SCHORK et al. 1995) , in a cycloheximide chase experiment at the nonpermissive temperature of 37˚C. After wild-type and cim3-1 cells were shifted to 37˚C for 45 min, cycloheximide was added to inhibit protein synthesis, and Pom33-13xmyc protein levels were monitored by western blot analysis at the indicated times ( Figure   3C -D). Clb2, a cell cycle protein known to be degraded by the proteasome (DESHAIES 1997; SEUFERT et al. 1995) , served as a control that showed stabilization in cim3-1 ( Figure 3C , right), while histone H4 was a loading control since its levels and stability are unaffected by temperature, cycloheximide or proteasome inhibition. Pom33-13xmyc stability was unaffected by cim3-1 (Figure 3D ), suggesting that Pom33 is not a proteasome target.
If Pom33 is ubiquitinated, but not degraded, what role does Asi1-dependent ubiquitination play in regulation and function of Pom33? One attractive idea is that Asi1-dependent ubiquitination may modulate Pom33 INM distribution, similar to the way that ubiquitination of proteins is involved in different processes such as nucleocytoplasmic trafficking. Examples of this include p53, in which mono-ubiquitination is thought to expose a nuclear export signal (LI et al. 2003; LOHRUM et al. 2001; NIE et al. 2007 ) and cytidydyltransferase (CCTalpha) where monoubiquitination blocks its nuclear localization signal (CHEN AND MALLAMPALLI 2009). To test this idea, we employed an inducible version of Asi1 fused to the deubiquitinating domain of Herpes Virus UL36 (Asi1-DUb) (MACDONALD et al. 2012; MACDONALD et al. 2017) . This Asi1-DUb is designed to deubiquitinate Asi1 targets as Asi1 acts on them. Although Asi1-DUb had little effect on total Pom33 protein levels, its induction resulted in increased frequency and extent of Pom33-GFP1-10 puncta formation at the INM ( Figure 3E -G), a phenotype very similar to the asi1∆. The appearance of the Pom33 puncta upon induction of the Asi1-DUb suggest that their formation is a direct consequence of deubiquitination and supports the idea that Asi1-dependent ubiquitination of Pom33 regulates its INM distribution.
If ubiquitination of Pom33 contributes to its normal INM distribution, then constitutive ubiquitination by fusion of ubiquitin to Pom33 might rescue the puncta phenotype seen in asi1∆ mutants. To test this, we first measured the INM intensity, using split-GFP signal, of Pom33-GFP1-10 and Ub-Pom33-GFP1-10 in wild-type and asi1∆ cells by split-GFP levels, finding that UbPom33-GFP1-10 partially recused overall INM intensity in asi1∆ ( Figure 4A-B) . Next, we compared the frequency and size of puncta in wild-type and asi1∆ containing Pom33-GFP1-10 or Ub-Pom33-GFP1-10 expressed in single copy at the URA3 locus as the sole copy of POM33 in the cell. As expected, the frequency and size of Pom33-GFP1-10 puncta increased in asi1∆ compared to wild-type ( Figure 4A-C) . However, expression of Ub-Pom33-GFP1-10 rescued the frequency and size phenotypes in asi1∆ cells, with fewer puncta ( Figure 4A -C) as well as smaller puncta size ( Figure 4C, bottom) . Therefore, attaching ubiquitin to Pom33 bypasses the requirement for Asi1 for INM distribution, strongly suggesting Asi1 directly modifies Pom33.
Because modification of N-terminal residues can affect protein stability through the N-end rule pathway (TASAKI et al. 2012; VARSHAVSKY 1992) , we examined expression levels by western blotting. This analysis showed that Pom33-GFP1-10 and Ub-Pom33-GFP1-10 were present at similar levels in wild-type cells ( Figure 4D ).
Pom33 INM puncta contain NPC components
Punctate distribution at the NE has been previously reported for spindle pole body (SPB), nuclear-vacuolar junction (NVJ), intranuclear quality control (INQ) and storage for incomplete NPC (SINC) components: Spc42, Nvj1, Cmr1 and Chm7, respectively (GALLINA et al. 2015; HUH et al. 2003; WEBSTER et al. 2014; WEBSTER AND LUSK 2016; . After replacing GFP11-mCherry-Pus1 with GFP11-Pus1, we examined colocalization of split-GFP signal in Pom33-GFP1-10 strains using mCherry-tagged proteins marking each of these NE puncta-associated structures. In most cells, Pom33-GFP1-10 did not colocalize with any of the tested NE proteins ( Figure S4 ). Moreover, if we deleted key components involved in the formation of nuclear sub-complexes, we did not see an effect on the size or frequency of Pom33 puncta ( Figure S4 ; data not shown). This result was particularly surprising as it suggests that Pom33 puncta represent a novel nuclear sub-compartment that is distinct, particularly from the SINC that has been previously described for incompletely assembled NPCs (WEBSTER et al. 2014; .
To better understand the nature of the Pom33 puncta, we were interested in determining if soluble nucleoporins not present in our screen were also present in foci. We localized at least one component from each NPC subcomplex in wild-type and asi1∆ cells, including the outer ring components Nup120 and Nup145C, the inner ring protein Nup188, the central channel component Nup57 and the basket proteins Nup2 and Mlp2 ( Figure 5A ) (AITCHISON AND ROUT 2012; ALBER et al. 2007 ). Nup145C, Nup57, Nup2 and Mlp2 were unaffected by removal of ASI1; however, Nup120 and Nup188 exhibited punctate foci specifically in asi1∆ mutants ( Figure 5B ). Over half of the Nup120-mCherry or Nup188-mCherry puncta seen in asi1∆ colocalize with Pom33-GFP1-10 ( Figure 5C ). While it is tempting to speculate that these puncta contain full or complete NPCs, it is important to note that we only observe puncta formation with a few nucleoporins. While we detected Pom33 in asi1∆ by immuno-electron microscopy (EM) at NPCs, there was no evidence of NPC clustering. Further, Pom33 did not localize to any recognizable NE landmark other than NPCs (data not shown), pointing to the possibility that Pom33 redistributes to a novel sub-nuclear component in the absence of Asi1.
Discussion
Mechanisms that control INM protein dynamics are poorly understood. Using split-GFP, we performed a systematic screen of over 700 membrane proteins, comparing INM levels between wild-type cells and mutants in the E3 ubiquitin ligases Asi1, Doa10 and Hrd1, the E2 ubiquitin conjugating enzyme Ubc7 and the vacuolar peptidase Pep4. Our data overlaps to a limited degree with previous studies examining substrates of these enzymes (FORESTI et al. 2014; KHMELINSKII et al. 2014) . However, our ability to specifically and unequivocally assay changes at the INM enabled us to extend our understanding of INM quality control in several important ways. Previous work hypothesized that the primary role of INMAD is to remove 'foreign'
substrates from the INM-proteins that have diffused in via NPCs but failed to diffuse back out, due to associated protein tags or lesions within the polypeptide (FORESTI et al. 2014; KHMELINSKII et al. 2014) . However, we found that deletion of ASI1 preferentially affected INM components compared to other mutants examined. In both our screen and our follow-up studies, we show that loss of ASI1 results in increased levels of bonafide INM proteins, such as Pom33, Per33, Asi2 and Heh2. This suggests that Asi1, and by extension INMAD, plays a role in proteostasis of wild-type INM proteins, not just proteins mistargeted to the INM.
The effects of ASI1 deletion on Pom33 distribution also shed light into the INMAD pathway.
Asi1 and Asi3 are thought to form a heterodimeric E3 ligase (FORESTI et al. 2014; ZARGARI et al. 2007 ), therefore, we anticipated that deletion of ASI3 would mimic asi1∆. However, we found that the number of Pom33 foci in asi3∆ was not statistically distinguishable from wild-type whereas it more than doubled in asi1∆ (Figure 2) . A similar observation was also made during studies of Asi1 regulation (PANTAZOPOULOU et al. 2016) , pointing to an incomplete understanding of the core INMAD enzymatic machinery. Given that Asi1 and Asi3 are multispanning membrane proteins, it has been difficult to set up in vitro biochemical assays to study their activity. However, several lines of evidence suggest that Pom33 is a direct Asi1 substrate.
First, Pom33 is ubiquitinated in an Asi1-dependent manner. Second, expression of Asi1-DUb recapitulated the Pom33 puncta phenotype seen in asi1∆ mutants. Lastly, a constitutively ubiquitinated Pom33 (Ub-Pom33) largely reversed puncta formation in asi1∆. Taken together, these data suggest that Asi1 normally acts to ubiquitinate a pool of Pom33, which results in its uniform NE distribution.
Asi1-dependent Pom33 ubiquitination does not appear to be a signal for degradation. A ladder of poly-ubiquitinated Pom33 was not observed. In addition, Pom33 levels did not change when it was fused to ubiquitin or expressed in a proteasome mutant. Our data suggest that ubiquitination regulates Pom33 localization in much the same way that mono-ubiquitination is used throughout the endomembrane system to control subcellular localization or endocytosis
(D'AZZO et al. 2005; HICKE AND DUNN 2003). Analysis of Pom33 localization determinants in
budding yeast suggest that the C-terminal 65 amino acids are important for both stability and NPC localization (FLOCH et al. 2015) , making it tempting to speculate that residues in this region are ubiquitinated. Attempts to map a ubiquitinated lysine residue were unsuccessful, suggesting that multiple lysines are sufficient (data not shown). Examination of our Asi1 substrates, along with previously described targets, did not show a particular motif targeting them to the ligase. However, it has been previously proposed that amphipathic helices play a role in Asi2 degradation and Doa10 substrate recognition (BOBAN et al. 2014; RAVID et al. 2006) .
Given that Pom33 has at least two amphipathic helices in its C-terminus that play a role in NPC targeting and membrane binding, one hypothesis is that these domains are also important for Asi1-dependent ubiquitination. More generally, INMAD-dependent control of these common motifs could play a role in regulation of NPC assembly and NE compartmentalization.
What is the role of INMAD regulation of Pom33 and other resident INM proteins? No obvious changes to nuclear structure, including NPC distribution, have been reported for asi1∆ by EM (FORESTI et al. 2014) . Colocalization with Nup120 and Nup188 suggests that the Pom33 puncta contain at least some additional NPC components even though no recognizable NPCs were seen cytologically (data not shown). We do not believe that these are improperly assembled NPCs, as puncta did not colocalize with the SINC. Instead, our data suggests that Pom33 aggregates in a novel INM structure. Since the INMAD has only been investigated for its role in degradation of targets, it will be of future interest to determine whether the INMAD components mediate ubiquitination of other proteins to alter their localization or if TMEM33, the metazoan ortholog of Pom33, is also ubiquitinated.
Materials & Methods
Yeast strains and plasmids
All strains are derivatives of BY (can1Δ::STE2pr-Sp-HIS5 lyp1Δ his3Δ1 leu2ΔO ura3ΔO met15ΔO LYS2). The split-GFP library was made by first integrating the pRS315-NOP1pr-GFP11-mCherry-PUS1 (pSJ1321) reporter into a MATα derivative to create SLJ7859 (MATα can1Δ::STE2pr-Sp-HIS5 lyp1Δ his3Δ1 leu2ΔO ura3ΔO met15ΔO LYS2 pLEU2-NOP1pr-
GFP11-mCherry-PUS1)
. Genes were C-terminally tagged with GFP1-10-URA3MX (pSJ1256) by PCR as previously described. These 1010 strains were crossed to deletion mutants taken from the yeast deletion collection (MATa yfg∆::KANMX LYP1 CAN1 his3 ura3 leu2) using the Singer RoToR robot as previously described (TONG AND BOONE 2006) . Following diploid selection on SD/MSG-Ura+G418, cells were sporulated for 3-4 weeks then haploids containing the deletion and the tags were selected twice on SD/MSG-Ura-His-Lys-Arg+thialysine+canavanine+G418.
All plates were incubated at 23°C. We did not recover certain combinations of deletion mutants/tagged genes/selection markers due to linkage and slow growth of certain strains.
Therefore, mutant libraries contained fewer genes than the original library. A complete list of genes screened can be found in Tables S1 and S2. For colocalization experiments, we used the pRS315-NOP1pr-GFP11-PUS1 (pSJ1679) Reporter so that genes could be C-terminally tagged with mCherry using pFA6-mCherry-KANMX by PCR. Strains used for each experiment are listed in Table S4 , with the exception of strains taken directly from our split-GFP libraries.
INM mutant screen
Cells were grown overnight at 23°C in SC-Leu in 96 well plate format, using deep well dishes (Thermo-Scientific). Imaging plates (Ibidi) were pretreated with 100 µl of poly-lysine (SigmaAldrich) for 1 h and then rinsed twice with water and allowed to dry before use. Cells were plated using 100 µl of culture. Each plate was imaged on a Nikon Eclipse TI equipped with a Yokogawa CSU W1 spinning disk head and Andor EMCCD using a Nikon Apo TIRF 100X 1.49NA Oil objective. mCherry was imaged using a 561nm laser at 100% power and ET605/70m emission filter, with an exposure time of 100 ms. GFP was imaged using a 488nm laser at 100% power and ET535/30m emission filter, with an exposure time of 200 ms. Four points were automatically selected for each well. An automation script moved to positions, found focus using Nikon PFS, and imaged each channel with a z-stack of 13 slices and spacing 0.5 µm. Image processing was performed in ImageJ using custom macros and plugins. In brief, images were background subtracted and sum projected in z, and for each cell a mask of the nucleus was generated based on the mCherry channel, as well as a ring mask surrounding the nucleus to measure cytoplasmic signal. mCherry and GFP intensity was measured in the nuclear and ring masks for each cell. Cells with high cytoplasmic signal were discarded as dead cells. For each live cell, the nuclear GFP/mCherry intensity ratio was calculated; from these data the average ratio per sample was calculated, and for each protein the mutant/wild-type ratio was calculated from these averages (given in Table S1 ). Proteins were counted as hits if the mutant/wild-type ratio was greater than 1.4.
Wild-type and asi1∆ images were manually inspected for signal in both the 561 nm and 488 nm channels. If no signal was present upon visual inspection, the sample was categorized as a false-positive and was removed from subsequent analysis with all mutants. These genes are listed in Table S2 ; most correspond to negatives or non-abundant INM hits in wild-type cells (SMOYER et al. 2016) .
Confocal imaging
Cells were grown overnight in SC-Leu in 2 ml cultures and then harvested for imaging and immobilized on poly-lysine slides (Polysciences Inc). Imaging was conducted on a Zeiss-LSM780. All images were taken using a 40x water objective, fluorophores were excited using a 488-nm and 561 nm Argon laser line, GFP emission was collected through a BP 505-540 nm filter and mCherry was collected through a LP 580 nm filter, with the pinhole set to 1 airy units.
Images taken for puncta quantification, puncta measurement and colocalization experiments had a zoom of 6, z stack of 10 -12 slices. Puncta widths were measured from manually drawn line profiles over puncta averaged over a thickness of 8 pixels. Profiles were then aligned to their peak maxima and averaged to determine average peak profiles. They were then fit to Gaussian functions using non-linear least squares to determine their width. Error bars were determined from monte carlo analysis with 100 random simulations as previously described (BEVINGTON AND ROBINSON 2003) .
Ubiquitination of Pom33
Liquid nitrogen ground lysates were prepared as previously described in (BUPP et al. 2007; FRIEDERICHS et al. 2012; JASPERSEN et al. 2006) . Cells of indicated genotypes were grown overnight, then diluted into 1 liter cultures in the morning to an OD600 of ~0.2. Cells were allowed to grow until mid-log phase and then harvested. Extraction buffer was adjusted for each sample so that an OD600 of 1.0 would have 5 ml of extraction buffer added. Cells were then dropped into liquid nitrogen to make yeast dots and then frozen at -80°C. Yeast powder was made by grinding the frozen yeast dots using Retsch ball mill 4 x 3 min, 30 Hz. Powder was then collected and weighed out to equal amounts for each sample. Ground cell powder was thawed on ice, then resuspended in 9 mL of extraction buffer (20 mM Hepes-NaOH, pH 7.5; 300 mM NaCl; 1 mM EDTA; 5 mM EGTA; 50mM NaF; 50 mM β-glycerophosphate; 0.5% TritonX-100; 1 mM DTT; 1 mM PMSF; and 1 mg/mL each pepstatin A, aprotinin, and leupeptin). Next, samples were homogenized with a Polytron 10/35 for 30 sec, lysates were centrifuged at 3000 × g for 10 min. at 4°C and the resulting supernatant was used for immunoprecipitations. Lysates were added to protein G Sepharose beads (GE Healthcare) that had been previously incubated with P4D1 anti-Ubiquitin antibody (1:500 µl, Cell Signaling Technology) and rotated for ~ 3 hours at 4°C. Beads were washed 5x with extraction buffer before western blot analysis, using (1:1000) anti-GFP antibody (Cell Signaling Technology).
Cycloheximide chase experiments
Cells were grown overnight and diluted back the next morning, then allowed to recover to midlog phase before the addition of cycloheximide (125 µg/ml). Samples were removed at given time points and quick frozen in liquid nitrogen for further analysis by western blotting, using A. Immunoprecipitation (IP) of an untagged control strain, Ubiquitin-Pom33-GFP 1-10 , Pom33-GFP 1-10 and asi1∆ Pom33-GFP 1-10 using an anti-Ubiquitin antibody, followed by immunoblot analysis using an anti-GFP antibody. A. Example images of Pom33-GFP 1-10 , asi1∆ Pom33-GFP 1-10 , Ub-Pom33-GFP 1-10 and asi1∆ Ub-Pom33-GFP 1-10 . B. Quantification of strains in A; intensities measured as a ratio of GFP 1-10 (488) signal over Pus1 (561) signal. C. For strains depicted in A, the frequency of Pom33-GFP 1-10 puncta was counted (top) and the average puncta width measured by (FWHM) of fluorescence intensity at the puncta (bottom). Total n depicted on graphs. Error bars equal SEM. D. Quantitation of total protein levels for Pom33-GFP 1-10 , asi1∆ Pom33-GFP 1-10 , Ub-Pom33-GFP 1-10 and asi1∆ Ub-Pom33-GFP 1-10 by western blot. Levels were first normalized to histone H4 signal and the levels of each compared to wild-type on left; ratios set at bottom. Bar, 2 μm. Nucleoporins tested included the outer ring components Nup120 and Nup145C, the inner ring Nup188, the central channel nucleoporin Nup57 and the basket associated Mlp2 and Nup2. B. Localization of nucleoporins in A were assayed in wild-type and asi1∆. Nup120 and Nup188 displayed more puncta in asi1∆, as indicated by blue arrows. C. Example images of Pom33-GFP 1-10 with either Nup120-mCherry or Nup188-mCherry in wild-type and asi1∆. Bar, 2 μm. A. Pom33-GFP 1-10 puncta did not colocalize with the SPB. B. Left, example images of Pom33-GFP 1-10 puncta, Nvj1-mCherry puncta (NVJ), and both in the same cell. Right, quantitation of puncta frequency, n = 198 cells total. C. Left, example images of Pom33-GFP 1-10 puncta, Cmr1-mCherry puncta (INQ), and both in the same cell. Right, quantitation of puncta frequency, n = 80 cells total. D. Left, example images of Pom33-GFP 1-10 puncta, Chm7-mCherry puncta (SINC), and both in the same cell. Right, quantitation of puncta frequency, n = 150 cells total. E. Disruption of CHM7 did not change Pom33 puncta formation. Bars, 2 μm. Error bars equal SEM.
